Version May 2024
| Laboratory testing |
| Complete blood count and differential |
| Coagulation studies (INR, PTT) |
| Iron, TIBC, ferritin |
| Glucose, hemoglobin A1C |
| Complete metabolic panel (electrolytes, liver function tests, BUN, creatinine) |
| Pregnancy test in females of childbearing age |
| Urinalysis |
| Brain natriuretic peptide¶ |
| Vitamin D level |
| Type and cross match (ABO) |
| Highly sensitive, solid-phase assays for HLA I and II antibodies |
| Serum/urine cotinine |
| Toxicology screen in patients with prior or suspected illicit drug use |
| Assessment for prior/current infections |
| Cytomegalovirus (CMV) IgG/IgM |
| Epstein Barr virus (EBV) IgG/IgM |
| Hepatitis B and C serologies |
| Herpes simplex (HSV) IgG/IgM |
| Human immunodeficiency virus (HIV) |
| Varicella zoster (VZV) IgG/IgM |
| Coccidioides IgG/IgMΔ |
| Toxoplasma IgG/IgMΔ |
| Strongyloides IgGΔ |
| Tuberculin skin testΔ |
| Sputum gram stain and culture |
| Breathing tests |
| Spirometry pre and post bronchodilator |
| Lung volumes by plethysmography |
| Diffusing capacity for carbon monoxide |
| Six-minute walk test |
| Arterial blood gas |
| Imaging |
| Chest radiograph |
| Chest computed tomography |
| Quantitative nuclear ventilation perfusion scan |
| Cardiac tests |
| Electrocardiogram |
| Echocardiogram or radionuclide ventriculography (RVG) |
| Cardiac catheterization (right and left heart) for patients over age 45¶ |
| Health maintenance review to ensure the candidate is up to date on these screening tests |
| DEXA bone density test (within two years) |
| Colonoscopy (within 10 years, if over age 50 years) |
| Mammogram and Pap smear (for women) in the past year |
| Prostate specific antigen and digital rectal examination of prostate (for men) |
| Dental examination |
| Assessment of gastric esophageal reflux and gastric emptying¶ |
| Barium swallow |
| Impedance pH probe monitoring |
| Esophageal manometry |
| Esophagogastroduodenoscopy (EGD) if concerns about Barrett esophagus, reflux esophagitis |
| Vaccinations |
| Hepatitis A and B (if not already immune) |
| Pneumococcal pneumonia vaccines (pneumococcal conjugate vaccine [13-valent], pneumococcal polysaccharide vaccine [PPS23]) |
| Seasonal influenza vaccine |
INR: international normalized ratio; PTT: partial thromboplastin time; TIBC: total iron binding capacity; A1C: glycated hemoglobin; BUN: blood urea nitrogen; HLA: human leukocyte antigen; DEXA: dual-energy x-ray absorptiometry.
* This table provides an overview of testing of potential lung transplant candidates, but the exact tests performed depend on the specific patient's history and the practice of the individual lung transplant center.
¶ Some centers use a noninvasive test for cardiac ischemia in patients without risk factors for coronary disease and reserve catheterization for patients with risk factors or a positive noninvasive test.
Δ Testing varies among centers based on geographic location or clinical history. As examples, some centers may only assess brain natriuretic peptide in patients with pulmonary hypertension, Coccidioides serology in patients who have resided in the southwestern United States, TST in patients from TB endemic areas, or tests for gastroesophageal reflux in patients with a history of reflux or symptoms suggestive of esophageal dysmotility.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
